Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 584 | 731 | 615 | 809 | 527 |
| Receivables | 25 | 24 | 11 | 48 | 326 |
| TOTAL | $2,234 | $1,475 | $1,556 | $2,142 | $2,283 |
| Non-Current Assets | |||||
| Intangibles | 870 | 902 | 935 | 968 | 1,592 |
| Other Non-Current Assets | 50 | 50 | 50 | 50 | 50 |
| TOTAL | $920 | $952 | $985 | $1,018 | $1,642 |
| Total Assets | $3,154 | $2,427 | $2,541 | $3,160 | $3,925 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 841 | 995 | 1,398 | 1,269 | 1,727 |
| Other current liabilities | 8,126 | 5,603 | 3,873 | 2,660 | 3,355 |
| TOTAL | $8,967 | $6,598 | $5,271 | $3,929 | $5,357 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 275 |
| Other Non-Current Liabilities | 6,063 | 5,807 | 5,565 | 5,342 | 3,912 |
| TOTAL | $6,062 | $5,807 | $5,564 | $5,334 | $3,964 |
| Total Liabilities | $15,029 | $12,405 | $10,835 | $9,263 | $9,321 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,078 | 1,077 | 1,077 | 1,077 | 1,077 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -105,748 | -103,590 | -101,635 | -99,161 | -97,073 |
| Other shareholders' equity | -43 | -42 | -42 | -41 | -137 |
| TOTAL | $-11,875 | $-9,978 | $-8,294 | $-6,103 | $-5,396 |
| Total Liabilities And Equity | $3,154 | $2,427 | $2,541 | $3,160 | $3,925 |